glp 1 and addiction treatment IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target GLP-1 Agonists: Expanding Horizons in

Meisha.

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects

Personalized hormone therapy, medical weight loss, peptides, IV therapy, and primary care in Colorado Springs

As tirzepatide and other GLP-1based therapies continue to dominate headlines, this study offers an important glimpse at where the future of inflammatory disease treatment may be headed

Premium Quality You Can Trust: Produced in a cGMP-certified, third-party tested facility, ensuring every capsule meets the highest standards of purity and potency

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years